Xtrackers S&P MidCap 400 ESG ETF MIDE 深 沪
等待开盘 10-20 09:30:00 美东时间
31.861
+0.163
+0.51%
华盛通- 最 高31.861
- 今 开31.6983
- 成交量 12股
- 最 低 31.861
- 昨 收 31.6983
- 总市值 573.50万
- 52周最高 33.0202
- 市盈率 静 --
- 换手率 0.01%
- 52周最低 24.8046
- 委 比 0.00%
- 总股本 18.00万
- 历史最高 33.0202
- 量 比 0.02
- 振 幅 0.00%
- 历史最低 20.5721
- 每 手 1
- 风险率 1.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AstraZeneca’s ARTEMIDE-Lung03: A Promising Phase III Study in Lung Cancer Treatment
AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), As...
07-15 00:09
Laxmi Dental Limited Expands Investment and Appoints New Secretarial Auditors
Laxmi Dental Ltd. ( ($IN:LAXMIDENTL) ) just unveiled an update. Laxmi Dental Li...
03-21 22:54
Xtrackers S&P MidCap 400 ESG ETF declares quarterly distribution of $0.0645
Xtrackers S&P MidCap 400 ESG ETF (NYSEARCA:MIDE) - $0.0645. Payable 22.03.24; for shareholders of record Mar 18; ex-div Mar 15. More on Xtrackers S&P MidCap 400 ESG ETF Seeking Alpha’s Quant Rating on...
2024-03-22 23:10
Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today?
Gilead Sciences Inc (NASDAQ: GILD) announced an agreement with Compugen Ltd (NASDAQ: CGEN) to license its pre-clinical antibody program against IL-18 binding protein exclusively, including the
2023-12-19 23:36
